It was also discovered that antagonism of AHR with the small molecule inhibitor StemReginin 1 improves engraftment and expansion of CD34 cells into NK cells ex vivo, adding further rationale to study the therapeutic efficacy of AHR inhibition in AML therapeutics [86,87]. The gene discussed is AHR; the disease is acute myeloid leukemia.